| Analysis | Metabolite Name | Measured Value | Units | Group | Treatment | Sample Source |
|---|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | L-Leucine | 1.7 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 2.5 | uL(plasma), pmole/mg (muscle) | batch1 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 2.5 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 2.7 | uL(plasma), pmole/mg (muscle) | batch1 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 2.7 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 2.9 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 3.1 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 3.2 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 3.3 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 3.4 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 3.5 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 3.6 | uL(plasma), pmole/mg (muscle) | batch1 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 3.8 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 3.9 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 3.9 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 4.8 | uL(plasma), pmole/mg (muscle) | batch1 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 4.9 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 4.9 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 5 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 5.2 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 5.4 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 5.5 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 5.8 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 6.4 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 7.7 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 7.9 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 8.5 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 9 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Leucine | 580 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 641 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 677 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 719 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 765 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 791 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 801 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 833 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 892 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 905 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 909 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 913 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 920 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 940 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 963 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 986 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 1010 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 1030 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 1130 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 1160 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 1160 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 1180 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 1190 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 1190 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 1220 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 1320 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 1360 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 1370 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 1420 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Leucine | 1490 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|